Prevalence of HIV Protease Mutations on Failure of Nelfinavir-Containing HAART: A Retrospective Analysis of Four Clinical Studies and Two Observational Cohorts-Reference-Cited by-同舟云学术

Prevalence of HIV Protease Mutations on Failure of Nelfinavir-Containing HAART: A Retrospective Analysis of Four Clinical Studies and Two Observational Cohorts

Published:2002-08 Issue:4 Volume:3 Page:316-323
ISSN:1528-4336
Container-title:HIV Clinical Trials
language:en
Short-container-title:HIV Clinical Trials

Author:

Bonaventura Clotet¹,Lidia Ruiz¹,Javier Martinez-Picado¹,Eugènia Negredo²,Andrew Hill³,Matei Popescu⁴

Affiliation:

1. Retrovirology Laboratory "IrsiCaixa" Foundation

2. Foundation "Lluita Contra la SIDA," Hospital Germans Trias I Pujol, Badalona, Barcelona, Spain

3. F Hoffmann-La Roche, Welwyn Garden City, United Kingdom

4. F Hoffmann-La Roche, Basel, Switzerland

Publisher

Informa UK Limited

Subject

Pharmacology (medical),Infectious Diseases

Link

https://www.tandfonline.com/doi/pdf/10.1310/67TE-GPXQ-R1LB-BPKG

Reference25 articles.

1. Antiviral and resistance studies of AG1343, an orally bioavailable inhibitor of human immunodeficiency virus protease

2. Genotypic and Phenotypic Characterization of Human Immunodeficiency Virus Type 1 Variants Isolated from Patients Treated with the Protease Inhibitor Nelfinavir

3. Replicative Fitness of Protease Inhibitor-Resistant Mutants of Human Immunodeficiency Virus Type 1

4. Sequencing of protease inhibitor therapy: insights from an analysis of HIV phenotypic resistance in patients failing protease inhibitors

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Data-intensive analysis of HIV mutations;BMC Bioinformatics;2015-02-05

2. Structural Basis of Why Nelfinavir-Resistant D30N Mutant of HIV-1 Protease Remains Susceptible to Saquinavir;Chemical Biology & Drug Design;2015-01-09

3. HIV Type 1 Antiretroviral Resistance Mutations in Subtypes B, C, and F in the City of São Paulo, Brazil;AIDS Research and Human Retroviruses;2010-03

4. Strategies for the optimal sequencing of antiretroviral drugs toward overcoming and preventing drug resistance;Future HIV Therapy;2007-09

5. Genotypic Human Immunodeficiency Virus Type 1 Drug Resistance in Highly Active Antiretroviral Therapy-Treated Children in Abidjan, C??te d??Ivoire;The Pediatric Infectious Disease Journal;2005-12